Universal Insurance Holdings (UVE) Earnings Analysis
Universal Insurance Holdings (UVE) next reports earnings on 2026-07-23, consensus EPS 1.62 USD. Last quarter (2026-04-23) it beat with EPS 2 USD vs 1.39 USD est (+43.9%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 5.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does UVE next report earnings?
| Next earnings date | 2026-07-23 |
|---|---|
| Consensus EPS estimate | 1.62 USD |
| Revenue estimate | 0.61B |
UVE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 2 USD | 1.39 USD | +43.9% | Beat |
| 2025-10-23 | 1.36 USD | 1.1 USD | +23.6% | Beat |
| 2025-07-24 | 1.23 USD | 1.09 USD | +12.8% | Beat |
| 2024-10-24 | -0.73 USD | -1.03 USD | +29.1% | Beat |
| 2024-07-25 | 1.18 USD | 1.02 USD | +15.7% | Beat |
Beat rate: 5/5 (100%) over reported quarters with consensus data.
UVE valuation and analyst view
| Trailing P/E | 5.38 |
|---|---|
| Trailing EPS | 7.03 USD |
| Price / book | 1.80 |
| Dividend yield | 2.04% |
| Market cap | 1.06B |
| Analyst consensus | Hold (1 buy / 2 hold / 1 sell) |
| Avg price target | 44 USD |
Related research pages
Frequently asked questions
When is Universal Insurance Holdings (UVE)'s next earnings date?
Universal Insurance Holdings is next scheduled to report on 2026-07-23, with a consensus EPS estimate of 1.62 USD and revenue estimate of 0.61B.
Did UVE beat earnings last quarter?
In its 2026-04-23 report, UVE posted EPS of 2 USD versus a 1.39 USD estimate — a beat of 43.9%.
What is UVE's earnings track record?
Over the last 5 reported quarters with consensus data, UVE beat estimates 5 times (100%).
What is UVE's current P/E ratio and EPS?
UVE trades at a trailing P/E of 5.38 on trailing EPS of 7.030268212990557 USD.
What do analysts rate UVE?
Analyst consensus is "Hold" across 4 ratings (0 strong buy, 1 buy, 2 hold, 1 sell, 0 strong sell). Average 12-month price target: 44 USD.